Literature DB >> 22681572

Synthesis and characterization of methylated poly(L-histidine) to control the stability of its siRNA polyion complexes for RNAi.

Shoichiro Asayama1, Takao Kumagai, Hiroyoshi Kawakami.   

Abstract

Poly(L-histidine) (PLH) with dimethylimidazole groups has been synthesized as a pH-sensitive polypeptide to control the stability of its small interfering RNA (siRNA) polyion complexes for RNA interference (RNAi). The resulting methylated PLH (PLH-Me) was water-soluble despite deprotonation of the imidazole groups at physiological pH, as determined by acid-base titration and solution turbidity measurement. Agarose gel retardation assay proved that the quaternary dimethylimidazole groups worked as cationic groups to retain siRNA. The stability of the PLH-Me/siRNA complexes has depended on the content of hydrophobic groups, that is, τ/π-methylimidazole groups as well as deprotonated imidazole groups. PLH-Me exhibited no significant cytotoxicity despite the existence of cationic dimethylimidazole groups. By use of PLH-Me as a pH-sensitive siRNA carrier, the PLH-Me/siRNA complexes mediated efficient siRNA delivery attributed to the dimethylimidazole groups, and the gene silencing depended on the content balance among dimethyl, τ/π-methyl, and unmodified imidazole groups. These results suggest that PLH-Me controls the stability of siRNA polyion complexes by enhancing noncytotoxic siRNA delivery by optimizing the content balance of dimethyl, τ/π-methyl, and unmodified imidazole groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22681572     DOI: 10.1021/bc300044r

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  5 in total

Review 1.  Non-viral gene delivery systems for tissue repair and regeneration.

Authors:  Pan Wu; Haojiao Chen; Ronghua Jin; Tingting Weng; Jon Kee Ho; Chuangang You; Liping Zhang; Xingang Wang; Chunmao Han
Journal:  J Transl Med       Date:  2018-02-15       Impact factor: 5.531

2.  A combination hepatoma-targeted therapy based on nanotechnology: pHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH.

Authors:  Mei Lin; Junxing Huang; Xingmao Jiang; Jia Zhang; Hong Yu; Jun Ye; Dongsheng Zhang
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

Review 3.  The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges.

Authors:  Jiaxi He; Songhui Xu; A James Mixson
Journal:  Pharmaceutics       Date:  2020-08-14       Impact factor: 6.321

4.  Screening for Methylated Poly(l-histidine) with Various Dimethylimidazolium/Methylimidazole/Imidazole Contents as DNA Carrier.

Authors:  Shoichiro Asayama; Takao Kumagai; Hiroyoshi Kawakami
Journal:  Pharmaceutics       Date:  2015-08-25       Impact factor: 6.321

5.  Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes.

Authors:  Zhongjian Chen; Tianpeng Zhang; Baojian Wu; Xingwang Zhang
Journal:  Int J Nanomedicine       Date:  2016-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.